Starke Robert M, McCarthy David J, Chen Ching-Jen, Kano Hideyuki, McShane Brendan J, Lee John, Patibandla Mohana Rao, Mathieu David, Vasas Lucas T, Kaufmann Anthony M, Wang Wei Gang, Grills Inga S, Cifarelli Christopher P, Paisan Gabriella, Vargo John, Chytka Tomas, Janouskova Ladislava, Feliciano Caleb E, Sujijantarat Nanthiya, Matouk Charles, Chiang Veronica, Hess Judith, Rodriguez-Mercado Rafael, Tonetti Daniel A, Lunsford L Dade, Sheehan Jason P
1Department of Neurological Surgery, University of Miami, Florida.
2Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.
J Neurosurg. 2019 Mar 15;132(4):1209-1217. doi: 10.3171/2018.12.JNS182208. Print 2020 Apr 1.
The authors performed a study to evaluate the hemorrhagic rates of cerebral dural arteriovenous fistulas (dAVFs) and the risk factors of hemorrhage following Gamma Knife radiosurgery (GKRS).
Data from a cohort of patients undergoing GKRS for cerebral dAVFs were compiled from the International Radiosurgery Research Foundation. The annual posttreatment hemorrhage rate was calculated as the number of hemorrhages divided by the patient-years at risk. Risk factors for dAVF hemorrhage prior to GKRS and during the latency period after radiosurgery were evaluated in a multivariate analysis.
A total of 147 patients with dAVFs were treated with GKRS. Thirty-six patients (24.5%) presented with hemorrhage. dAVFs that had any cortical venous drainage (CVD) (OR = 3.8, p = 0.003) or convexity or torcula location (OR = 3.3, p = 0.017) were more likely to present with hemorrhage in multivariate analysis. Half of the patients had prior treatment (49.7%). Post-GRKS hemorrhage occurred in 4 patients, with an overall annual risk of 0.84% during the latency period. The annual risks of post-GKRS hemorrhage for Borden type 2-3 dAVFs and Borden type 2-3 hemorrhagic dAVFs were 1.45% and 0.93%, respectively. No hemorrhage occurred after radiological confirmation of obliteration. Independent predictors of hemorrhage following GKRS included nonhemorrhagic neural deficit presentation (HR = 21.6, p = 0.027) and increasing number of past endovascular treatments (HR = 1.81, p = 0.036).
Patients have similar rates of hemorrhage before and after radiosurgery until obliteration is achieved. dAVFs that have any CVD or are located in the convexity or torcula were more likely to present with hemorrhage. Patients presenting with nonhemorrhagic neural deficits and a history of endovascular treatments had higher risks of post-GKRS hemorrhage.
作者开展了一项研究,以评估脑硬脑膜动静脉瘘(dAVF)的出血率以及伽玛刀放射外科治疗(GKRS)后出血的危险因素。
从国际放射外科研究基金会收集了一组接受GKRS治疗脑dAVF患者的数据。每年的治疗后出血率计算为出血次数除以患者的风险人年数。在多变量分析中评估了GKRS前及放射外科治疗后潜伏期内dAVF出血的危险因素。
共有147例dAVF患者接受了GKRS治疗。36例患者(24.5%)出现出血。在多变量分析中,存在任何皮质静脉引流(CVD)(比值比[OR]=3.8,p=0.003)或凸面或窦汇部位的dAVF更有可能出现出血(OR=3.3,p=0.017)。一半的患者曾接受过治疗(49.7%)。4例患者发生了GKRS后出血,潜伏期内的总体年风险为0.84%。Borden 2-3型dAVF和Borden 2-3型出血性dAVF的GKRS后年出血风险分别为1.45%和0.93%。闭塞经影像学确认后未发生出血。GKRS后出血的独立预测因素包括非出血性神经功能缺损表现(风险比[HR]=21.6,p=0.027)和既往血管内治疗次数增加(HR=1.81,p=0.036)。
在实现闭塞之前,患者放射外科治疗前后的出血率相似。存在任何CVD或位于凸面或窦汇的dAVF更有可能出现出血。出现非出血性神经功能缺损且有血管内治疗史的患者GKRS后出血风险更高。